Cargando…

The Majority of United States Citizens With Cancer do not Have Access to Carbon Ion Radiotherapy

As of December 31, 2020, there were 12 facilities located in Asia and Europe which were treating cancer patients with carbon ion radiotherapy (CIRT). Between June 1994 and December 2020, 37,548 patients were treated with CIRT worldwide. Fifteen of these patients were United States (U.S.) citizens. U...

Descripción completa

Detalles Bibliográficos
Autores principales:	Foote, Robert L., Tsujii, Hirohiko, Imai, Reiko, Tsuji, Hiroshi, Hug, Eugen B., Kanai, Tatsuaki, Lu, Jiade J., Debus, Juergen, Engenhart-Cabillic, Rita, Mahajan, Anita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304691/ https://www.ncbi.nlm.nih.gov/pubmed/35875126 http://dx.doi.org/10.3389/fonc.2022.954747

Ejemplares similares

Dosimetric robustness against setup errors in charged particle radiotherapy of skull base tumors
por: Ammazzalorso, Filippo, et al.
Publicado: (2014)

Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery
por: Guckenberger, Matthias, et al.
Publicado: (2020)

Students’ learning behavior in digital education for radiation oncology
por: Vorwerk, Hilke, et al.
Publicado: (2021)

Up-to-date results of carbon-ion radiotherapy for prostate cancer
por: Nomiya, Takuma, et al.
Publicado: (2014)

Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial
por: Combs, Stephanie E, et al.
Publicado: (2012)

Carbon Ion Beam Reirradiation in Recurrent High-Grade Glioma
por: Eberle, Fabian, et al.
Publicado: (2020)

A phantom based evaluation of the dose prediction and effects in treatment plans, when calculating on a direct density CT reconstruction
por: Flatten, Veronika, et al.
Publicado: (2020)

The fast calibration model for dosimetry with an electronic portal imaging device
por: Schade, Stephanie, et al.
Publicado: (2022)

Anti-Proliferative Effect of Radiotherapy and Implication of Immunotherapy in Anaplastic Thyroid Cancer Cells
por: Wächter, Sabine, et al.
Publicado: (2023)

A Review of Update Clinical Results of Carbon Ion Radiotherapy
por: Tsujii, Hirohiko, et al.
Publicado: (2012)

Making the right software choice for clinically used equipment in radiation oncology
por: Vorwerk, Hilke, et al.
Publicado: (2014)

Carbon ion radiotherapy in a hypofractionation regimen for stage I non-small-cell lung cancer
por: Takahashi, Wataru, et al.
Publicado: (2014)

Siah1 proteins enhance radiosensitivity of human breast cancer cells
por: He, Hai-Tao, et al.
Publicado: (2010)

Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?
por: Santiago, Alina, et al.
Publicado: (2016)

Changes of lung parenchyma density following high dose radiation therapy for thoracic carcinomas – an automated analysis of follow up CT scans
por: Schröder, Christina, et al.
Publicado: (2019)

Carbon Ion Radiotherapy for Oligo-Recurrence in the Lung
por: Yamamoto, Naoyoshi, et al.
Publicado: (2013)

Advantage of proton-radiotherapy for pediatric patients and adolescents with Hodgkin’s disease
por: Lautenschlaeger, S., et al.
Publicado: (2019)

Dosimetric impact of reduced nozzle-to-isocenter distance in intensity-modulated proton therapy of intracranial tumors in combined proton-carbon fixed-nozzle treatment facilities
por: Jelen, Urszula, et al.
Publicado: (2013)

Carbon ion radiotherapy for basal cell adenocarcinoma of the head and neck: preliminary report of six cases and review of the literature
por: Jingu, Keiichi, et al.
Publicado: (2010)

Safety and Efficacy of Botulinum Toxin to Preserve Gland Function after Radiotherapy in Patients with Head and Neck Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blinded Phase I Clinical Trial
por: Teymoortash, Afshin, et al.
Publicado: (2016)

P097: The status quo of involved-field radiotherapy – Quality analysis of radiotherapy in the GHSG HD 16
por: Oertel, Michael, et al.
Publicado: (2022)

Efficiency analysis of rapid antigen test based SARS-CoV-2 in hospital contact tracing and screening regime: test characteristics and cost effectiveness
por: Zirbes, Julian, et al.
Publicado: (2023)

Correction to: Effects of the Bragg peak degradation due to lung tissue in proton therapy of lung cancer patients
por: Baumann, Kilian-Simon, et al.
Publicado: (2020)

Effects of the Bragg peak degradation due to lung tissue in proton therapy of lung cancer patients
por: Baumann, Kilian-Simon, et al.
Publicado: (2019)

P092: Estimating the dosimetric benefit of involved-node radiotherapy in comparison to involved-field radiotherapy - implications from the GHSG HD 17 trial
por: Oertel, Michael, et al.
Publicado: (2022)

Five-year quality of life assessment after carbon ion radiotherapy for prostate cancer
por: Maruyama, Katsuya, et al.
Publicado: (2017)

Increased expression of EphA7 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients
por: Wang, Lin-Fang, et al.
Publicado: (2008)

Commissioning of carbon‐ion radiotherapy for moving targets at the Osaka Heavy‐Ion Therapy Center
por: Hamatani, Noriaki, et al.
Publicado: (2021)

In HPV-Positive HNSCC Cells, Functional Restoration of the p53/p21 Pathway by Proteasome Inhibitor Bortezomib Does Not Affect Radio- or Chemosensitivity()()
por: Seltzsam, Steve, et al.
Publicado: (2018)

Monocentric evaluation of Ki-67 labeling index in combination with a modified RPA score as a prognostic factor for survival in IDH-wildtype glioblastoma patients treated with radiochemotherapy
por: Dumke, R., et al.
Publicado: (2022)

Progressive hypofractionated carbon‐ion radiotherapy for hepatocellular carcinoma: Combined analyses of 2 prospective trials
por: Kasuya, Goro, et al.
Publicado: (2017)

Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancer
por: Xia, Peng, et al.
Publicado: (2009)

Establishment of a Transformation Coupled in vitro End Joining Assay to Estimate Radiosensitivity in Tumor Cells
por: Degenhardt, Sarah, et al.
Publicado: (2020)

The clinical relative biological effectiveness and prostate‐specific antigen kinetics of carbon‐ion radiotherapy in low‐risk prostate cancer
por: Kang, Yu‐Mei, et al.
Publicado: (2022)

Do citizens have minimum medical knowledge? A survey
por: Bachmann, Lucas M, et al.
Publicado: (2007)

Significant impact of biochemical recurrence on overall mortality in patients with high‐risk prostate cancer after carbon‐ion radiotherapy combined with androgen deprivation therapy
por: Kasuya, Goro, et al.
Publicado: (2016)

Carbon‐ion radiotherapy for urological cancers
por: Ishikawa, Hitoshi, et al.
Publicado: (2022)

Status in Japan
por: Prof. TSUJII, Hirohiko
Publicado: (2014)

Comparison of Oncologic Outcomes and Treatment-Related Toxicity of Carbon Ion Radiotherapy and En Bloc Resection for Sacral Chordoma
por: Yolcu, Yagiz U., et al.
Publicado: (2022)

In cancer cell lines inhibition of SCF/c-Kit pathway leads to radiosensitization only when SCF is strongly over-expressed
por: Eberle, Fabian, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_54lm88bsq0mk188kfon9lmrrf5